Angucyclines and Angucyclinones

Preferred Label : Angucyclines and Angucyclinones;

MeSH definition : Polycyclic aromatic polyketides with tetracyclic angular benz(a)anthracene skeletons. Angucyclines and related angucyclinones are produced by Actinomycetes, e.g., STREPTOMYCES, using type II polyketide synthase involving condensation of acetyl CoA and 9 malonyl-CoA.;

MeSH synonym : Angucyclinones and Angucyclines; Angucycline and Angucyclinone Derivatives;

MeSH hyponym : Angucycline Aglycons;

Details

Origin ID

D000095602;

UMLS CUI

C5828268;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Record concept(s)
- Angucycline Antibiotics [MeSH concept]
- Angucyclines [MeSH concept]
- Angucyclines and Angucyclinones [MeSH concept]
- Angucyclinone Antibiotics [MeSH concept]
- Angucyclinones [MeSH concept]
Related MeSH Supplementary Concept(s)
- 4-deacetyl-4-O-isobutyrylkinamycin C [MeSH Supplementary Concept]
- MM 47755 [MeSH Supplementary Concept]
- aquayamycin [MeSH Supplementary Concept]
- difluostatin A [MeSH Supplementary Concept]
- fujianmycin B [MeSH Supplementary Concept]
- kerriamycin A [MeSH Supplementary Concept]
- kerriamycin B [MeSH Supplementary Concept]
- kerriamycin C [MeSH Supplementary Concept]
- kinamycin A [MeSH Supplementary Concept]
- kinamycin C [MeSH Supplementary Concept]
- kinamycin D [MeSH Supplementary Concept]
- kinamycin E [MeSH Supplementary Concept]
- kinamycin F [MeSH Supplementary Concept]
- kinamycin J [MeSH Supplementary Concept]
- lomaiviticin A [MeSH Supplementary Concept]
- lomaiviticin B [MeSH Supplementary Concept]
- pre-kinamycin [MeSH Supplementary Concept]
- rabelomycin [MeSH Supplementary Concept]
- rubiginone B1 [MeSH Supplementary Concept]
- rubiginone B2 [MeSH Supplementary Concept]
- rubiginone C(1) [MeSH Supplementary Concept]
- rubiginone C(2) [MeSH Supplementary Concept]
- rubiginones [MeSH Supplementary Concept]
- saquayamycin [MeSH Supplementary Concept]
- saquayamycin B [MeSH Supplementary Concept]
- saquayamycin C [MeSH Supplementary Concept]
- saquayamycin D [MeSH Supplementary Concept]
- saquayamycin E [MeSH Supplementary Concept]
- saquayamycin F [MeSH Supplementary Concept]
- saquayamycin Z [MeSH Supplementary Concept]
- tetrangomycin [MeSH Supplementary Concept]
See also
- anthraquinones [MeSH Descriptor]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients